Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Scientific Reports
|
June 23, 2026
HB reduces inflammation in HUVECs via the Nrf2/HO-1 axis by inhabiting apoptosis and oxidative stress
Xiaoyu Zhang, Chunlin Cong, Hui Cao, et al.
Cell Research
|
August 28, 2013
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system
Albert W Cheng, Haoyi Wang, Hui Yang, et al.
Arthritis Research & Therapy
|
November 29, 2025
Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials
Laure Gossec, Andra Balanescu, Maria Antonietta D'Agostino, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 10, 2020
Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma
Shuixia Tan, Jing Zhao, Ziyu Sun, et al.
Nature Communications
|
December 14, 2020
Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners
Xingyan Li, Mengmeng Zhang, Xinyue Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 25, 2023
Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e
Xing Wang, Renxia Zhang, Dong Yang, et al.
Scientific Reports
|
January 13, 2021
Development and validation of a multiplex 19 X-chromosomal short tandem repeats typing system for forensic purposes
Juan Jia, Xu Liu, Qingwei Fan, et al.
Cell
|
May 1, 2012
Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells
Hui Yang, Linyu Shi, Bang-An Wang, et al.
Nature Communications
|
August 27, 2017
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Jiefei Geng, Yasushi Ito, Linyu Shi, et al.
Nature Communications
|
December 11, 2025
A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab
Andrew Blauvelt, Rundong Jiang, Linyu Shi, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Scientific Reports
|
June 23, 2026
HB reduces inflammation in HUVECs via the Nrf2/HO-1 axis by inhabiting apoptosis and oxidative stress
Xiaoyu Zhang, Chunlin Cong, Hui Cao, et al.
Cell Research
|
August 28, 2013
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system
Albert W Cheng, Haoyi Wang, Hui Yang, et al.
Arthritis Research & Therapy
|
November 29, 2025
Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials
Laure Gossec, Andra Balanescu, Maria Antonietta D'Agostino, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 10, 2020
Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma
Shuixia Tan, Jing Zhao, Ziyu Sun, et al.
Nature Communications
|
December 14, 2020
Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners
Xingyan Li, Mengmeng Zhang, Xinyue Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 25, 2023
Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e
Xing Wang, Renxia Zhang, Dong Yang, et al.
Scientific Reports
|
January 13, 2021
Development and validation of a multiplex 19 X-chromosomal short tandem repeats typing system for forensic purposes
Juan Jia, Xu Liu, Qingwei Fan, et al.
Cell
|
May 1, 2012
Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells
Hui Yang, Linyu Shi, Bang-An Wang, et al.
Nature Communications
|
August 27, 2017
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Jiefei Geng, Yasushi Ito, Linyu Shi, et al.
Nature Communications
|
December 11, 2025
A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab
Andrew Blauvelt, Rundong Jiang, Linyu Shi, et al.
Page
of 9